<!DOCTYPE html>

<html lang="en">
<head>
<meta charset="utf-8"/>
<title>article11</title>
<style>
        body {
            font-family: Arial, sans-serif;
            margin: 0;
            padding: 0;
            background-color: #f3f3f3;
        }
        .container {
            max-width: 800px;
            margin: auto;
            background: #fff;
            padding: 20px;
            box-shadow: 0 0 10px rgba(0, 0, 0, 0.1);
        }
        h1, h2 {
            color: #333;
        }
        p {
            line-height: 1.6;
        }
        a {
            text-decoration: none;
            color: #5a5a5a;
        }
        a:hover {
            color: #000;
        }
    </style>
</head>
<body>
<div class="container"><p><a href="../index_gpt.html">Back to Index</a></p><li><a href="https://www.wikijournalclub.org/wiki/MADIT-II" style="display:block; margin-bottom:10px;">MADIT-II Original</a></li>
<h2><strong>MADIT-II</strong></h2>
<div class="container">
<h2><strong></strong></h2>
<div class="container">
<div class="container">
<h2><strong></strong></h2>
<h2><strong></strong></h2>

    "Prophylactic Implantation of a Defibrillator in Patients with Myocardial Infarction and Reduced Ejection Fraction". The New England Journal of Medicine. 2002. 346(12):877-883.<br/>
<br/>
<h2><strong>Contents</strong></h2><br/>
1 Clinical Question<br/>
2 Bottom Line<br/>
3 Major Points<br/>
4 Guidelines<br/>
5 Design<br/>
6 Population<br/>
6.1 Inclusion Criteria<br/>
6.2 Exclusion Criteria<br/>
6.3 Baseline Characteristics<br/>
7 Interventions <br/>
8 Outcomes<br/>
8.1 Primary Outcome<br/>
9 Criticisms<br/>
10 Funding<br/>
11 Further Reading<br/>
<br/>
<h2><strong>Clinical Question</strong></h2><br/>
Does prophylactic implantation of a defibrillator improve survival among patients with a prior myocardial infarction and reduced left ventricular ejection fraction?<br/>
<br/>
<h2><strong>Bottom Line</strong></h2><br/>
Prophylactic implantation of a defibrillator in patients with prior myocardial infarction and a left ventricular ejection fraction of 0.30 or less improves survival.<br/>
<br/>
<h2><strong>Major Points</strong></h2><br/><br/>
<br/>
<h2><strong>Guidelines</strong></h2><br/><br/>
<br/>
<h2><strong>Design</strong></h2><br/>
- Multicenter, randomized controlled trial<br/>
- N=1232 patients with prior MI and ejection fraction ≤0.30<br/>
- Intervention: Implantable defibrillator (n=742)<br/>
- Control: Conventional medical therapy (n=490)<br/>
- Primary outcome: Death from any cause<br/>
- Follow-up: Average of 20 months<br/>
<br/>
<h2><strong>Population</strong></h2><br/>
Inclusion Criteria<br/>
- Prior myocardial infarction<br/>
- Left ventricular ejection fraction ≤0.30<br/>
<br/>
Exclusion Criteria<br/>
- Contraindications for defibrillator<br/>
- Recent MI or revascularization<br/>
- Advanced non-cardiac diseases<br/>
<br/>
Baseline Characteristics<br/>
- Similar between groups<br/>
- Medication use at last follow-up was also comparable<br/>
<br/>
<h2><strong>Interventions</strong></h2><br/>
- Transvenous defibrillator implantation in the intervention group<br/>
- Standard medical treatment in the control group<br/>
<br/>
<h2><strong>Outcomes</strong></h2><br/>
Primary Outcome<br/>
- 19.8% mortality in conventional therapy group<br/>
- 14.2% mortality in defibrillator group<br/>
- Hazard ratio for death: 0.69 (95% CI, 0.51 to 0.93; P=0.016)<br/>
<br/>
<h2><strong>Criticisms</strong></h2><br/>
- The incidence of heart failure requiring hospitalization was higher in the defibrillator group.<br/>
- The cost and resource implications of widespread prophylactic implantation are substantial.<br/>
<br/>
<h2><strong>Funding</strong></h2><br/>
The study was supported by a research grant from Guidant to the University of Rochester School of Medicine and Dentistry. Some authors disclosed financial relationships with Guidant.<br/>
<br/>
<h2><strong>Further Reading</strong></h2><br/>
The trial publication and relevant additional literature involve advancements in the field of cardiac electrophysiology and criteria for defibrillator implantation post-MI.
    <p></p>
</div>
</div>
</div>
</div>
</body>
</html>
